Jason Golan
Director/Board Member presso Valneva UK Ltd.
Provenienza dei contatti di primo grado di Jason Golan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The private company is based in London, UK and was founded in 2015.
3
| Subsidiary | Medical/Nursing Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jason Golan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Ottawa | College/University | Masters Business Admin | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member | |
GSK Vaccines GmbH
 GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GSK Vaccines GmbH is a German company that manufactures and distributes pharmaceutical products. The private company is based in Marburg, Germany. The company was founded in 2009. Christopher Hunley has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chief Executive Officer | |
| Atlantic Biotherapies | Chief Executive Officer | ||
| Technische Hochschule Mittelhessen | College/University | Graduate Degree | |
| VALNEVA | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman | |
| Smol Therapeutics SAS | Chief Executive Officer | ||
| Vivalis Toyama Japan KK | Chairman | ||
| Grimaud Deyang Animal Co. Ltd. | Director/Board Member | ||
| Chengdu Grimaud Breeding Co. Ltd. | Director/Board Member | ||
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The private company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| Elatos GmbH | Chief Executive Officer | ||
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The private company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Chief Executive Officer Chairman | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Intercell Austria AG | Corporate Officer/Principal Chief Executive Officer | ||
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The private company is based in Kirkland, Canada. | Medical Distributors | President Director/Board Member | |
| Grätzelmixer GmbH | Chief Executive Officer | ||
| Valneva USA, Inc. | Chief Executive Officer Chief Executive Officer | ||
Pays de la Loire Participations
 Pays de la Loire Participations Investment ManagersFinance Investissement pour le Développement des Entreprises l'Emploi is designed to invest in small and mid cap companies based in the Pays de la Loire region of France. The fund will invest mainly in innovative companies with a profitable track record and help them in their growth by taking minority participation. | Investment Managers | Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 8 |
| Austria | 6 |
| Stati Uniti | 4 |
| Canada | 3 |
| Germania | 3 |
Settori
| Health Technology | 11 |
| Commercial Services | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 20 |
| Chief Executive Officer | 16 |
| President | 9 |
| Corporate Officer/Principal | 8 |
| Chairman | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Franck Grimaud | 22 |
| Thomas Lingelbach | 17 |
| Wolfgang Bender | 4 |
- Borsa valori
- Insiders
- Jason Golan
- Connessioni Società
